Detalhe da pesquisa
1.
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
Blood
; 140(16): 1753-1763, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512188
2.
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
Blood
; 138(18): 1733-1739, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115096
3.
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
BMC Cancer
; 22(1): 368, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392843
4.
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment.
Am J Hematol
; 97(11): 1443-1452, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054614
5.
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax.
Cancer
; 127(20): 3772-3781, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255353
6.
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.
Br J Haematol
; 192(6): 1054-1063, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618432
7.
Falls Due to Loss of Consciousness are Associated With Maxillofacial Fracture Severity.
J Oral Maxillofac Surg
; 78(3): 423-429, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31783003
8.
Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review.
J Oral Maxillofac Surg
; 76(1): 97-111, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654766
9.
Oral-maxillofacial trauma of a geriatric population in a super-ageing country.
Dent Traumatol
; 33(6): 433-437, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28887864
10.
Impalement of an unusual foreign body on the temporomandibular joint causing severe trismus.
Dent Traumatol
; 32(6): 514-516, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27425371
11.
Retinoic acid-inducible gene-I-like receptor (RLR)-mediated antiviral innate immune responses in the lower respiratory tract: Roles of TRAF3 and TRAF5.
Biochem Biophys Res Commun
; 467(2): 191-6, 2015 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454171
12.
Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer.
Support Care Cancer
; 23(11): 3323-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25987235
13.
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity.
Leukemia
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467769
14.
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Nat Commun
; 15(1): 1203, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331987
15.
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity.
Res Sq
; 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986825
16.
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
Bone Marrow Transplant
; 57(3): 370-376, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992253
17.
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib.
Leukemia
; 36(5): 1253-1260, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132195
18.
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.
Lancet Haematol
; 9(5): e350-e360, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483396
19.
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
Nat Commun
; 13(1): 2801, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589701
20.
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
Blood Adv
; 5(8): 2173-2183, 2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33885753